Chronic disease, drug claims driving benefits plan costs: report
Growth in chronic disease and increased drug claims are two of the key factors driving up the cost of private health benefit plans, according to a new report by Innovative Medicines Canada. It found that chronic diseases accounted for 68 per cent of drug plan claims costs and 79 per cent of growth. Claims costs […]
- January 15, 2021 April 14, 2021
- 15:00